# Lotte Biologics completes acquisition of Bristol Myers Squibb plant in Syracuse

Lotte Biologics completed the acquisition of a plant from Bristol Myers Squibb in Syracuse, New York for $160 million on January 1, 2023, to develop it as its North American center.

- Type: Acquisition
- Announced: 2023-01-01
- Where: Syracuse, New York, United States
- Value: $160.0M
- Status: completed
- Products: antibody-drug conjugates, clinical supplies
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Lotte Biologics](https://endata.com/companies/67798.md) (acquirer)
- [Bristol Myers Squibb](https://endata.com/companies/67799.md) (target)

## Sources

- [pulse.mk.co.kr](https://pulse.mk.co.kr/news/english/10602664), 2023-01-11: "Lotte Biologics completed the acquisition of a plant from global biopharmaceutical company Bristol Myers Squibb in Syracuse, New York for $160 million on Jan. 1"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.